Phenomix Sciences Raises $7.8M to Expand MyPhenome Test and Drive Market Growth

Phenomix Sciences' Funding and MyPhenome Test

Key Highlights:

• Funding: Raised $7.8 million in funding, including $5.5 million in Series A funding from new investors DexCom, Inc. and Labcorp, and existing investors.
• MyPhenome Test: Developed the MyPhenome test, which helps physicians develop personalized treatment plans for obesity by identifying obesity phenotypes.
• Commercialization and Adoption: Capital will accelerate the commercialization and adoption of the MyPhenome test in the obesity specialist market and the wider industry.

Phenomix Sciences' Target Market

• Target Market: Obesity specialists, healthcare providers, and pharmaceutical companies.
• Obesity Treatment Providers: Physicians and healthcare professionals specializing in obesity treatment and management.
• Pharmaceutical Companies: Companies developing obesity medications and therapies, seeking partnerships for precision medicine approaches.

What Phenomix Sciences Needs to Buy

• Clinical Research Support: Collaborations with research institutions and healthcare providers for conducting clinical studies on obesity precision medicine.
• Strategic Partnerships: Partnerships with pharmaceutical companies and healthcare providers to further develop and launch phenotyping tests and expand market reach.
• Marketing and Sales Support: Services to support the commercialization and adoption of the MyPhenome test, including marketing and sales strategies.